UK Infected Blood Inquiry-An Historical Appraisal

Area of Science:

• Haematology
• Infectious Diseases
• Public Health Policy

Background:

• Appraisal of the 2018 UK Infected Blood Inquiry (IBI) and its 2024 Report.
• Contextualizes the IBI within 55 years of haemophilia treatment advancements and the AIDS pandemic.
• Focuses on the inquiry's findings regarding Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS).

Purpose of the Study:

• To critically appraise the conduct and conclusions of the Infected Blood Inquiry (IBI) and its Report.
• To evaluate the IBI's findings in relation to HIV and AIDS transmission in haemophilia patients.

Main Methods:

• Personal perspective based on clinical experience treating haemophilia patients since 1969.
• Informed by contemporaneous scientific publications and historical records.
• Critical analysis of the IBI Report's methodology, findings, and omissions.

Main Results:

• Commends the Report for recommending compensation and acknowledging improvements in blood safety.
• Critiques the delay in establishing a no-fault compensation system for HIV-infected individuals.
• Hypothesizes that the inquiry's structure necessitated finding fault to justify compensation, potentially leading to omissions and hindsight bias.

Conclusions:

• The IBI Report falls short in providing a comprehensive, evidence-based history of HIV infection in haemophilia.
• The Report overlooks the dedication and professionalism of treatment services in combating blood-borne infections.
• Calls for a more complete historical narrative and recognition of healthcare professionals' efforts.